3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with clopidogrel in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, Y; Li, S; Liu, S; Wang, E; Xie, R; Yuan, D; Zhang, W; Zhu, X | 1 |
1 review(s) available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and clopidogrel
| Article | Year |
|---|---|
Protease activated receptor 4 (PAR4) antagonists: Research progress on small molecules in the field of antiplatelet agents.
Topics: Animals; Blood Platelets; Drug Discovery; Humans; Indazoles; Indoles; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Small Molecule Libraries; Thiadiazoles | 2021 |